Oct 3, 2024 · the effectiveness of trintellix (vortioxetine) for treating depression was initially studied in five clinical trials that included adults aged 18 to 75 years old and one clinical trial. Trintellix is indicated for the treatment of major depressive disorder (mdd) in adults (1, 14). The dose should then be increased to 20 mg/day, as tolerated (2. 1). Trintellix (vortioxetine hydrobromide) is indicated for the treatment of major depressive disorder (mdd) in adults. The efficacy of trintellix in providing symptomatic relief of mdd.
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young.
